Swarmer, Inc. reported Q3 2026 financial results, highlighting its transition from a software provider to an integrated defense solutions supplier. The company is nearing the close of its acquisition of Ratel Robotics and announced a pending IP acquisition from Vataga Drone to bolster its hardware capabilities. Reported revenue for the quarter was $25,554, primarily from support services, as the pending Ratel acquisition's performance is not yet consolidated.
Term
Q3 2026
“The third quarter marked a pivotal period for Swarmer as we made meaningful progress toward our vision of bringing combat-tested technologies from Ukraine to allied nations.”
Alex Fink, Swarmer’s President and U.S. CEO
“Ground vehicles, air defense and integrated autonomous drone kits represent the three pillars of our expanding market position.”
BridgeBio Oncology Therapeutics reported a net loss of $34.2 million for the third quarter of 2026, an improvement from the $44.8 million loss in the prior year period. Total assets decreased to $346.2 million from $448.4 million at year-end 2025, primarily driven by a significant reduction in cash and cash equivalents as the company continues to fund its research and development operations.
Airgain, Inc. reported sales of $15.3 million for the third quarter of 2026, a 9.3% increase compared to the same period in 2025. The company narrowed its net loss to $0.6 million for the quarter, down from a $1.0 million loss in the prior year, driven by higher gross profit and reduced operating expenses.
Marchex reported third quarter 2026 financial results, returning to revenue growth and GAAP profitability with $16.0 million in revenue and $1.3 million in net income. The company highlighted commercial momentum following its Archenia acquisition, including the expansion of AI Voice Agent deployments and automotive OEM distribution. Additionally, Travis Fairchild was appointed as President of the company.
Term
Q3 2026
“Our third quarter results reflect a new phase of growth and meaningful progress in strengthening Marchex's financial performance, with year-over-year revenue growth, positive GAAP net income, and a significant improvement in Adjusted EBITDA.”
Russell Horowitz, Chairman of Marchex
“By bringing together Marchex's conversational intelligence and analytics with Archenia's AI-powered customer qualification and acquisition technologies, we are creating a differentiated platform that connects customer insights with automated actions and measurable business outcomes.”
Astronics Corporation reported record third quarter 2026 financial results, with sales growing 28.5% to $271.7 million and record operating income of $54.0 million. The company achieved a book-to-bill ratio of 1.00 and maintained its full-year 2026 revenue guidance of $1.02 billion to $1.04 billion.
“We delivered a strong third quarter, with record sales and operating income and an adjusted EBITDA margin near its all-time high. These results reflect disciplined operational execution and strong demand across our markets. Bookings were a solid $271.1 million following the prior quarter that had benefited from a couple of large program awards. We expect momentum to continue as we head into the final quarter of the year.”
Peter J. Gundermann, Chairman, President and Chief Executive Officer
This filing contains a Section 13(r) disclosure regarding a minority non-controlling interest in Malaysia Airports Holdings Berhad held by BlackRock affiliates. The disclosure reports that Iran Airtour resumed flight operations to one of the airports operated by Malaysia Airports Holdings Berhad starting in August 2026.
BridgeBio Oncology Therapeutics reported financial results for the third quarter of 2026, highlighting a cash runway expected to fund operations into 2029. The company reported clinical progress for its RAS-pathway inhibitors, including a 75% objective response rate for BBO-8520 in combination with pembrolizumab in certain lung cancer patients. Management expects monotherapy data updates for BBO-11818 and BBO-10203 in the fourth quarter of 2026.
Term
Q3 2026
“The third quarter was an important period for BBOT as we reported updated clinical data for BBO-8520 and delineated our strategic focus. Driven by encouraging clinical data across all three programs we are executing on multiple combinations with the potential for significant patient benefit.”
Pedro J. Beltran, Ph.D., Chief Executive Officer of BBOT
“With a strong balance sheet, multiple data catalysts expected through mid-2027, and cash runway into 2029, we believe BBOT is well positioned to advance differentiated therapies for patients with KRAS-driven cancers.”
Pedro J. Beltran, Ph.D., Chief Executive Officer of BBOT
Copper Property CTL Pass Through Trust reported net income of $12.99 million for the quarter ended September 30, 2026, a significant increase from $1.29 million in the prior year period, primarily due to the absence of a $10.67 million impairment charge recorded in 2025. The Trust's real estate portfolio consists of 117 retail properties, and it is currently in the process of extending its termination date to January 5, 2027.
PetMed Express reported second quarter fiscal year 2027 net sales of $35.8 million, a 19.4% decrease year-over-year driven by lower prescription sales. The company narrowed its net loss to $6.4 million compared to $8.5 million in the prior year, aided by reduced general, administrative, and advertising expenses. CEO Jeff Willard noted the company is focused on stabilizing operations and reducing customer acquisition costs, which fell 32% from the previous year.
Term
Q2 2027
“We have stabilized the operations of the business and our focus now is on transforming our core direct-to-consumer pharmacy business and making PetMeds a leaner, more profitable company at the size we are today.”
Jeff Willard, Chief Executive Officer and President of PetMeds
“We are already making progress: this quarter we cut our cost to acquire a new customer by 32% from a year ago. Next, we are repositioning the brand so pet parents know exactly why to choose PetMeds, making our marketing work harder, making our website easier to buy from, and keeping more of the customers we win.”
Jeff Willard, Chief Executive Officer and President of PetMeds
Skyworks Solutions reported higher operating expenses in fiscal 2026 due to a weakening U.S. dollar against the Mexican Peso and the enactment of the One Big Beautiful Bill Act (OBBBA). The company also completed a significant acquisition of Qorvo on October 5, 2026, which is expected to increase the complexity of its global tax profile and potential tax liabilities.
RideNow Group reported a net loss of $13.9 million for the third quarter of 2026, compared to a $4.1 million loss in the prior year, driven by lower powersports vehicle revenue and a $5.7 million loss on debt extinguishment. The company transitioned to a single-segment operation following the cessation of its vehicle transportation services business in late 2025.
Darling Ingredients reported a significant increase in net income for the nine months ended October 3, 2026, reaching $794.6 million compared to $11.5 million in the prior year period. This growth was primarily driven by a substantial turnaround in equity income from Diamond Green Diesel and increased total net sales of $5.07 billion.
American Integrity Insurance Group Financial Results
American Integrity Insurance Group reported record Q3 2026 revenue growth of 83% year-over-year, driven by a 57% increase in voluntary new business policies. The company achieved net income of $28.4 million and nearly doubled its net premiums earned to $101.2 million compared to the prior year period.
Term
Q3 2026
“We delivered another strong quarter that reflects the continued execution of our strategy and the increasing strength of our voluntary growth platform. Following record voluntary new business production in the second quarter, we sustained that momentum in the third quarter, writing approximately 41,000 voluntary new business policies, an increase of 57% year over year, and an acceleration from the second quarter’s year-over-year growth rate.”
Robert Ritchie, Chief Executive Officer
“Our growth remains grounded in the disciplined underwriting and thoughtful risk selection that have defined American Integrity for more than two decades. As we approach the important milestone of half a million customers, it remains imperative that we remain focused on the same core principles that have made American Integrity successful through various market cycles.”
Suja Life reported third quarter 2026 net sales of $76.4 million, a 3.3% increase year-over-year, driven by volume gains in cold-pressed juice and wellness shots. The company significantly improved its bottom line, with net loss narrowing to $8.3 million from $14.6 million and Adjusted EBITDA growing to $10.5 million. Management updated its full-year outlook, expecting roughly 70% Adjusted EBITDA growth for fiscal 2026.
Term
Q3 2026
“We continued to gain share of natural healthy beverage in the third quarter while most of the category’s largest players lost share. Even with continued pressure in grocery, we’re winning where shoppers are going, our newer lines are leading the way, and we expect adjusted EBITDA to grow roughly 70% this year, with margin expanding to nearly 20%, while investing deliberately behind our brands.”
Maria Stipp, Chief Executive Officer
“Owning our production gives us more control over our costs and supply, which helps us navigate inflationary pressures such as fuel, packaging and other inputs. We’re concentrating our investment on the brands, channels and programs with the potential of delivering the clearest returns, and we believe this positions Suja for more consistent, profitable growth over time.”
Narragansett Financial Corporation reported net income of $9.1 million for the nine months ended September 30, 2026, a significant increase from $3.2 million in the prior year period. The company is currently undergoing a reorganization into a two-tier holding company structure with Narragansett Bancorp, Inc. as the new mid-tier holding company.
Phoenix Energy One, LLC is a non-accelerated filer reporting 100,000,000 common shares outstanding as of November 9, 2026, all owned by Phoenix Equity Holdings, LLC. The company maintains a complex capital structure involving various debt instruments including Adamantium Bonds, Reg D/Reg A Bonds, and Phoenix Flex Notes to fund its exploration and production operations.
Fold Holdings, Inc. reported a significant decrease in total assets from $153.5 million at year-end 2025 to $52.2 million as of September 30, 2026, primarily driven by a reduction in digital assets held in the investment treasury. The company faces a potential Nasdaq delisting for failing to meet the minimum bid price requirement and is managing an accumulated deficit of $212.4 million.
CalciMedica reported a net loss of $4.35 million for the nine months ended September 30, 2026, a significant improvement from the $18.80 million loss in the prior year period, primarily driven by a $10.5 million gain from the change in fair value of financial instruments. Total operating expenses decreased to $14.37 million from $18.74 million, while the company strengthened its cash position through private placements and warrant exercises.
Texas Community Bancshares reported net income of $2.3 million for the nine months ended September 30, 2026, up from $2.0 million in the prior year period. The company saw an increase in net interest income to $10.8 million, though comprehensive income was negatively impacted by $1.1 million in net unrealized losses on available-for-sale securities.
Core & Main announced preliminary estimated financial results for the third quarter of fiscal 2026, reporting net sales between $2.12 billion and $2.13 billion. The company also updated its full-year Adjusted EBITDA outlook to a range of $950 million to $960 million and disclosed $171 million in quarterly share repurchases.
Spire Global reported Q3 2026 revenue of $18.0 million, a 42% year-over-year increase driven by Space Services and Weather data sales. The company improved its operating cash flow by 59% year-over-year and maintained a debt-free balance sheet with $78.0 million in cash. CEO Theresa Condor highlighted major contract wins with NOAA that provide significant revenue visibility into 2027 and beyond.
Term
Q3 2026
“Spire is entering a new phase of execution, and this quarter’s core business growth and major contract wins demonstrate our strong momentum. These multi-year awards give us greater revenue visibility into 2027 and beyond. With satellites in orbit, an established ground network and global manufacturing capabilities across the U.S., UK and Germany, we have the foundation to deliver on these commitments, grow efficiently and advance toward profitability.”
Terrestrial Energy Inc. reported a net loss of $30.9 million for the nine months ended September 30, 2026, compared to a $21.8 million loss in the prior year period, driven by a significant increase in general and administrative and R&D expenses. The company maintained a strong liquidity position with $276.3 million in cash and short-term investments as of the end of the quarter.
Factorial Energy Inc. reported a net loss of $11.1 million for the nine months ended September 30, 2026, a significant improvement from the $58.1 million loss in the prior year. The company successfully completed a reverse recapitalization and PIPE financing during the period, resulting in a total stockholders' equity of $95.4 million compared to a deficit of $221.4 million at the end of 2025.
Intelligent Protection Management Corp. reported a significant revenue increase to $23.8 million for the nine months ended September 30, 2026, driven primarily by a surge in procurement revenue. Despite the top-line growth, the company incurred a net loss for the period, resulting in an accumulated deficit of $28.1 million and a decrease in total stockholders' equity to $15.4 million.
Atara Biotherapeutics reported a decrease in cash and cash equivalents to $4.1 million as of September 30, 2026, down from $8.5 million at year-end 2025. The company is currently reviewing strategic alternatives and warns that it will require substantial near-term financing to continue operations, raising concerns about its ability to fund planned operations.
Netlist reported third quarter 2026 financial results with net sales rising 149% year-over-year to $105.1 million, driven by strong AI demand and initial license fees from Samsung. The company achieved a significant turnaround in profitability, reporting net income of $85.4 million compared to a net loss in the prior year period. Cash reserves strengthened substantially to $327.7 million following a $200 million initial payment from Samsung.
Term
Q3 2026
“We are pleased to report our third consecutive quarter of significant year-over-year revenue growth and improved profitability led by both product sales and the recognition of license revenue under our Samsung agreement. Year-over-year product revenue growth was driven by strong demand from customers in AI and data center applications.”
C.K. Hong, Chief Executive Officer
“Gross margins improved and was driven by our focus on higher margin opportunities. During the quarter, we substantially strengthened our balance sheet with the initial proceeds from our Samsung agreement and generated operating cash flow of $245 million.”
BTC Development Corp. reported a net income of $5.57 million for the nine months ended September 30, 2026, primarily driven by $6.89 million in interest earned on marketable securities held in its Trust Account. As a shell company, it has not yet generated operating revenue and is currently focused on identifying a target for a business combination.
Reed's, Inc. reported Q3 2026 financial results, highlighting a gross margin expansion to 25% and a 15% reduction in SG&A expenses. Despite a slight decline in net sales to $6.5 million, the company improved its net loss to $3.2 million and strengthened its balance sheet through a loan refinancing and a subsequent $10 million private placement.
Term
Q3 2026
“The third quarter marked another step forward in our operating performance, with continued progress on gross margin and cost discipline. During the quarter, we focused on expanding retail coverage through our national broker network, adding new placements and doors, restructuring e-commerce fulfillment to reduce costs, improving trade spend efficiency, and rebalancing our cost structure.”
Neal Cohane, Reed’s interim CEO
“We continue to make quarter-over-quarter progress. In the third quarter, gross margin expanded 100 basis points sequentially to 25%, selling, general and administrative expenses decreased 24% sequentially, and net loss decreased 26% sequentially.”
TELA Bio reported a net loss of $32.8 million for the nine months ended September 30, 2026, as revenue declined slightly to $57.3 million from $59.4 million in the prior year. A significant balance sheet shift occurred as $56.3 million in debt was reclassified to current liabilities, contributing to a total stockholders' deficit of $24.6 million.
Precipio reported record quarterly revenue of $7.3 million for Q3 2026, driven by growth in both its pathology and product segments. The company achieved positive Adjusted EBITDA of $0.4 million and generated $0.6 million in cash flow from operations, ending the period with a cash balance of $3.5 million.
Term
Q3 2026
“In the third quarter we continued to strengthen our financial position, delivering record revenue while maintaining positive Adjusted EBITDA and generating cash from operations.”
Ilan Danieli, CEO of Precipio
“Our pathology business continues to provide a strong operational and financial foundation for growth, while also serving as the clinical development and validation platform for our proprietary diagnostic products.”